New drug combo aims to stop liver cancer recurrence after surgery
NCT ID NCT07324824
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 2 trial is testing whether giving two drugs—sintilimab (an immunotherapy) and bevacizumab (a targeted therapy)—before surgery can help prevent liver cancer from coming back. The study includes 37 adults with resectable liver cancer that is beyond the Milan criteria, meaning it is more advanced than usual surgical limits. Participants will receive the drugs for a few cycles before surgery, and researchers will track how many remain cancer-free one year later.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- sintilimab and bevacizumab biosimilar (immunotherapy and targeted therapy drugs)
- What this could lead to
- If successful, this combination could become a standard pre-surgery treatment to lower the chance of liver cancer returning after surgery.
- What could go wrong
- This is a small, early-phase study with only 37 participants and no comparison group. The treatment may cause side effects, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BEVACIZIMAB are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, 510060, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Could a vaccine help fight Hard-to-Treat cancers?
- Can a Four-Drug combo erase Triple-Negative breast cancer before surgery?
- Could a tailored diet before surgery boost liver cancer recovery?
- Can a new PET tracer light up hidden cancers?
- A new test could reveal how radiation affects the liver